Viridian is dedicated to improving patients’ lives through the discovery and development of RNA-based therapeutics, with a specific focus on microRNAs.

Biotechnology

Viridian Therapeutics

Viridian Therapeutics' headquarters in Boulder, CO, United States

Shan Wu

Melissa Manno

Alyssa Yenikomshian

Jason A. Leverone

Mark Howansky

Steve Graunke

Partha Ghosh

Rochelle Summerfelt

Shula Pollard

Angela Doyle

Chelsea Gordon

Kellie Dinapoli

Subhabrata Biswas

Lucy Weng

Valerie Smith

Cindy Durkin

Thomas Beetham

Jeremy Brinkerhoff

Anabel Chan

Greg Rossino

Julianna Harding

Larisa D.

Martha Chadwick-Walker

Robert Stewart

Heather Haley

Keira Kim

Stephanie Lippe

Craig Moquin

Brian Krisak

Tricia Nguyen

Kathryn Hutnick

Jyothi Vijayaraghavan

Zeke Johnston

Vanessa Andresen

Lucas Greder

Linsey George

Michael Freibaum

Garry Vilnits

Sarah Jane Constantine

Kyle Haraldsen

Michael Fonseca

Jennifer Hou

Fabiana Marzabal

Shane Bouchard

Tara Mehan

Brian Wiercinski

Jennifer Gyarfas

Marvin H. Caruthers

Jeffrey S. Hatfield

Eric N. Olson

Victor R. Ambros

Michael R. Bristow

Jeffery D. Molkentin

Christopher Bowden

Kevin Koch

Arlene M. Morris

Thomas E. Hughes

Joe Turner

Stefanie Dimmeler

Eva Van Rooij

Frank Slack

The Scientific Team at Viridian Therapeutics drives the discovery and development of RNA-based therapeutics, concentrating on microRNA innovations. They conduct cutting-edge research, develop and refine processes, ensure regulatory compliance, and effectively communicate scientific advancements to support drug development and enhance patient outcomes.

Scientific Team

The Advisory Team at Viridian Therapeutics provides expert guidance on the strategic direction of RNA-based therapeutics development. Composed of seasoned advisors, the team leverages their vast experience in microRNA research and pharmaceutical development to inform decision-making, optimize project outcomes, and enhance patient-centric innovations.

Advisory Team

The Quality Control and Operations team at Viridian Therapeutics ensures the integrity and efficacy of RNA-based therapeutics by overseeing all aspects of quality assurance, from initial development through commercialization. This team streamlines operational processes, monitors compliance with regulatory standards, and supports the seamless transition of products from research to market.

Quality Control and Operations

The Clinical Development Team at Viridian Therapeutics is responsible for the strategic planning and execution of clinical trials to evaluate the efficacy and safety of RNA-based therapeutics. The team oversees trial design, regulatory compliance, patient recruitment, data collection, and analysis to ensure successful development of microRNA-targeted treatments.

Clinical Development Team

The Finance and Accounting Team at Viridian Therapeutics is responsible for managing the company’s financial health through accurate accounting practices, strategic financial planning, and analysis. They ensure regulatory compliance, oversee budget management, and provide financial insights to support the development of RNA-based therapeutics focused on microRNAs.

Finance and Accounting Team

The Business and Operations team at Viridian Therapeutics is responsible for strategic planning, regulatory compliance, operational efficiency, and intellectual property management. They ensure that the company's RNA-based therapeutics development aligns with business objectives, regulatory standards, and patent protections to drive innovation and market success.

Business and Operations

Viridian Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Advisory Team

Quality Control and Operations

Clinical Development Team

Finance and Accounting Team

Business and Operations

Offices

Viridian Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Advisory Team

Quality Control and Operations

Clinical Development Team

Finance and Accounting Team

Business and Operations

Offices

Related companies